Alex Gorsky

At 64 years old, Alex Gorsky physical status not available right now. We will update Alex Gorsky's height, weight, eye color, hair color, build, and measurements.

Gorsky joined Johnson & Johnson in 1988 as a sales representative in its pharmaceutical business unit, Janssen Pharmaceuticals. He held various management and leadership roles at Janssen before becoming Company Group Chairman overseeing Europe, Middle East, and Africa in 2003.

Gorsky led the marketing of products such as Risperdal. Ultimately Johnson & Johnson was fined $2.2 billion for strategies that downplayed the drug's side effects, encouraged off-label use, and provided kickback payments to Omnicare, a company that provided drug services to nursing homes.

Gorsky joined the Novartis Pharmaceuticals Corporation in 2004 as chief operating officer and head of General Medicines. In 2005, he was appointed Head of Pharmaceuticals North America and Chief Executive Officer. During his tenure, he created the CEO Diversity & Inclusion Award. He oversaw the growth of its cardiovascular and other franchises.

Gorsky returned to Johnson & Johnson in 2008 when he was appointed Company Group Chairman for Ethicon, Inc. In September 2009, he was promoted to Worldwide Chairman, Medical Devices & Diagnostics. Then-CEO William C. Weldon chose Gorsky to be Vice Chairman in the Office of the Chairman. On April 26, 2012, Gorsky was appointed Chief Executive Officer. On December 28, 2012, Gorsky was appointed Chairman of the Board. A longtime advocate of diversity and inclusion, Gorsky was named one of the "100 Most Inspiring Leaders" by Pharma Voice.

Gorsky oversaw the company's legal defense against talc class action suits and opioid lawsuits. In January 2020, Gorsky testified at the New Jersey trial about Johnson & Johnson's baby powder product.

Under Gorsky's leadership, the company stock more than tripled, and averaged more than a 15% annual return, surpassing the S&P 500. Johnson & Johnson's market capitalization went from nearly $180 billion to more than $470 billion.

"As the world's largest health care company, we are bringing to bear our best scientific minds, and rigorous standards of safety, in collaboration with regulators, to accelerate the fight against this pandemic," Gorsky said in New Jersey Business magazine in 2020. Gorsky attributed the strong multilayered immune response from J&J's vaccine to its innovative adenovirus-vector platform, AdVac, which it has developed over a decade.

Gorsky was the executive sponsor of the J&J Women's Leadership Initiative and the Veteran's Leadership Council. In 2021, with a salary of $23.14 million, he ranked second on the list of highest-paid CEOs in healthcare, according to Becker's Hospital Review.

Gorsky was the speaker at The Wharton School at the University of Pennsylvania 2022 MBA Graduation Ceremony.

Source

• Gorsky and his wife Pat donated to the Doylestown Health Foundation twice; $5 million in 2017 and $5 million in 2022.
• Mentor of the Year by the Healthcare Businesswomen's Association in 2009
• Joseph Wharton Leadership Award in 2014
• CADCA Humanitarian of the Year Award in 2014
• Corporate Humanitarian Award by Operation Smile in 2015
• Appeal of Conscience Award by Appeal of Conscience Foundation in 2015.
• ROBIE Award by the Jackie Robinson Foundation in 2017
• Ripple of Hope Award by Robert F Kennedy Human Rights in 2017
• Honorary Doctorate from Thomas Jefferson University in 2018
• Diversity Inc. Global Inclusive Leaders Award in 2018
• Honorary Doctorate from Ferris State University College of Health Profession and Michigan College of Optometry
• West Point Distinguished Graduate Award in 2020
• Gorsky was ranked #2 on the NJBIZ Manufacturing Power 50 list in 2020
• Legend in Leadership Award by Yale School of Management in 2021
• Red Jacket Award by PharmaVoice 2021
• BENS Eisenhower Award 2021
• Top 30 Modern Healthcare Leaders 2022